Anteris Technologies (ASX:AVR) logged a $0.30 loss per share for the second quarter, compared with a $0.58 loss per share a year ago, a Wednesday filing showed.
For the three months ended June 30, net sales reached $1 million versus $618,000 previously, the Australia-listed medical technology company added.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.